🚀 NEW PANEL ANNOUNCEMENT: Agentic Workflows in Bioinformatics at scverse 2025! 🚀 We're thrilled to introduce an exciting panel discussion at the upcoming scverse Conference 2025! More information in 🧵 #scverse2025 #Bioinformatics #AgenticAI #Conference

The first AI-generated microbial genomes by Arc Institute arcinstitute.org/news/hie-kin...

Pfizer's VP ML Enoch Huang, @broadinstitute.org's @drannecarpenter.bsky.social, Novartis VP Jeremy Jenkins, Formation Bio's Head of Data Sci Enrique Garcia-Rivera & Vertex alum Maria E. Morales r speakers on 9/19 AI panel at Harvard Biotech Club cc @cdbahl.com @dr-alphalyrae.bsky.social Link ⬇️

Congratulations to the team at Ridge Bio, using AI to develop technologies for precision bioconjugation/next gen biotherapeutics 👏 www.businesswire.com/news/home/20...

The expert and VC-led annual report —Decoding Bio Snapshot is out. It was a privilege being a coauthor with several colleagues. Check out our research on the concept of ‘virtual cells’ and future prognosis open.substack.com/pub/decoding...

Supervised learning in DNA neural networks www.nature.com/articles/s41...

For PhD students in my network, NVIDIA is now accepting applications for our graduate fellowship program. If you are working on topics across AI, life sciences, healthcare and HPC - consider applying. blogs.nvidia.com/blog/applica...

We are happy to announce that our latest manuscript has been published in Nature Communications! We identified the highly abundant and prevalent (>70% in population) giant (Max. 395kb) extrachromosomal element in the human mouth, named "Inocle". www.nature.com/articles/s41...

One of the reasons why LLMs won't replace biologists in the foreseeable future, from @dr-alphalyrae.bsky.social's X post today: #medsky #biosky

Parabricks, a genomics startup built to GPU-accelerate sequence analysis, was acquired by NVIDIA in 2020. The team has published work showing GPU-accelerated, universal analysis supporting major sequencing platforms: Illumina, Ultima, Singular, MGI, Element Biosciences, PacBio, and Oxford Nanopore.

Everyone working in a STEM field should read this - ‘writing is thinking’ www.nature.com/articles/s44...

Controlled colonization of the human gut with a genetically engineered microbial therapeutic | Science www.science.org/doi/10.1126/...

Computational exploration of global venoms for antimicrobial discovery with Venomics artificial intelligence | Nature Communications www.nature.com/articles/s41...

This weekend I met some amazing people at the inaugural event of The Knowledge Society in SF. This moment in time feels like a grand experiment in how advanced computing and artificial intelligence will alter humanity. Orgs like TKS are nurturing the next generation of scientists and entrepreneurs!

Another TechBio Berkeley Meetup on the way! 📅 Tues, July 22 | 5:30–7:30 PM 📍 Berkeley, CA (register to see location) Network with biotech builders, scientists & founders over brews. RSVP Now: lu.ma/n3boihud

We are hosting a community event with FutureHouse for SF Bay Area scientists, engineers and investors! I'll be there with some other colleagues from NVIDIA Digital Biology team. Find us! lu.ma/py6vsmp9

AI-enabled drug discovery reaches clinical milestone | Nature Medicine www.nature.com/articles/s41...

Microbe with bizarrely tiny genome may be evolving into a virus www.science.org/content/arti...

Our next San Diego meetup is happening on June 26th! Come by for brews and bio chatter! 🧬 lu.ma/r5rkhlrm

The NVIDIA healthcare & life sciences team just dropped a reasoning agent that can review papers, come up with complex hypotheses and then hand off results to a small molecule virtual screening agent. Check out a demo and instructions on how to try it in this tech blog

America is ceding the lead in creating the future | Science www.science.org/doi/10.1126/...

@alexr.bsky.social maybe this is the Boltz community you were looking for?: boltz.bio/boltz2

Boltz-2 launched today — Towards Accurate and Efficient Binding Affinity Prediction by MIT and @recursionpharma.bsky.social boltz.bio/boltz2

new Banksy in Versailles 🩵

Join us next week for a panel discussion with Surbhi Sarna, CEO of Collate, Oliver Hesse VP of digital transformation at Bayer and Jack Morel, Product lead a QbDVision. RSVP below - spots are limited 🧬 🧬 lu.ma/8x79mz8f

this is a good list!

ChatGPT can now handle SMILES strings 🧪⚛️

BrainStorm Therapeutics is accelerating the development of cures for neurological disorders by pairing AI-powered computational #drugdiscovery with human brain #organoids. Learn more in this article by @dr-alphalyrae.bsky.social feat. @mayagosztyla.bsky.social blogs.nvidia.com/blog/brain-d... 🧪

Robin: A multi-agent system for automating scientific discovery arxiv.org/abs/2505.13400

Regeneron is going to acquire 23andMe endpts.com/regeneron-pl...

Powerful CRISPR system inserts whole gene into human DNA | Nature www.nature.com/articles/d41...

See this? It's called a non-inferiority trial. It compares the new vaccine with the current vaccines to see if the new vaccine does better. This new vaccine did. Placebo-controlled trials are not needed to test most new vaccines. Demanding them will only reduce vaccine access. Which is the point.

the og drug discovery, inside an 1800s monastery pharmacy in Zurich. Complete with an upside down alligator hanging from the ceiling

A Cross-Species Generative Cell Atlas Across 1.5 Billion Years of Evolution: The TranscriptFormer Single-cell Model www.biorxiv.org/content/10.1...

Protein with twin binding sites for uranium extraction | National Science Review academic.oup.com/nsr/advance-...

SynBioBeta is coming up! We are co-organizing a Biomixer with Latinx Tech Group, Life Science Entrepreneur and Life Science Tech Collective! RSVP BELOW. Spots are limited and this event will fill up very fast lu.ma/fcbllthj

In a recent NVIDIA blog I talk about Brainstorm Tx, a techbio startup working on rare diseases using their AI platform and brain organoids. The blog highlights their use of BioNeMo framework and the Geneformer model. blogs.nvidia.com/blog/brain-d...

Along with a new Lilly partnership, BigHat extended its Series B from $75M to over $120M Preparing to be in the clinic next year: endpts.com/bighat-inks-...

Towards multimodal foundation models in molecular cell biology | Nature www.nature.com/articles/s41...

How to think about designing smart antibodies in the age of generative AI: integrating biology, technology, and experience www.tandfonline.com/doi/full/10....

GeneWhisperer: Enhancing manual genome annotation with large language models | bioRxiv www.biorxiv.org/content/10.1...

Dotmatics, the company that owns GraphPad Prism, Geneious and SnapGene was just acquired by Siemens for $5.1B. With plans to create AI-based software www.wsj.com/business/dea...

Isomorphic secures $600M in what’s arguably the toughest biotech funding season endpts.com/isomorphic-l...

AlphaFold is running out of data — so drug firms are building their own version www.nature.com/articles/d41...

Transformers and genome language models | Nature Machine Intelligence www.nature.com/articles/s42...

The first bifunctional protein degrader to deliver Phase III data! It seems to work, but people were definitely expecting more:

Identifying the genomic loci associated with brain aging and repurposing drugs targeted to their pathways science.org/doi/10.1126/...

How to watch Nvidia GTC 2025, including CEO Jensen Huang’s keynote

Hackathons have long been the lifeblood of tech innovation. And the field of TechBio is finally catching up! Tess from Lux Capital and I wrote about Evolved - an annual Bio x AI hackathon that has been hugely impactful in driving new software creation and nurturing the next generation of talent

NVIDIA’s GTC (GPU Tech Conference) is coming up in 2 weeks. This year, we’re bringing deep expertise in AI for neuroscience, drug discovery, clinical development, genomics, robotics, and image analysis. I’ll be there — DM me if you are going! 🧬✨